← Evidence map

ArticleAnnals of hematology2024

Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia.

Victor Pope et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37930364